Headache & Pain
News
FDA Provides Expanded Clearance for Device to Treat Migraine in Children
Thursday, February 28, 2019—The Food and Drug Administration (FDA) has granted new marketing clearance for a device that provides acute and preventive treatment of migraine to include children 12 years o…
FDA Clears Radio Frequency Nerve Tissue Ablation System for Treatment of Pain
Wednesday, February 27, 2019—The Food and Drug Administration (FDA) has cleared a radiofrequency (RF) nerve ablation system (Accurian; Medtronic, Dublin, Ireland) for the treatment of patients with chroni…
Nasally-Delivered CGRP Antagonist for Migraine Achieves Phase 1 Clinical Trial Targets
Wednesday, February 06, 2019—In a phase 1 clinical trial, it was shown that intranasal delivery of a third-generation calcitonin gene-related peptide antagonist reached therapeutic levels in treated parti…
Headache Horizons: Migraine Work in Translation
With Richard B. Lipton, MD
February 2019—From discovery of CGRP to the monoclonal antibodies of today and -gepants of tomorrow, basic science has been translated to clinical progress over just 3 decades.
Sumatriptan Nasal Spray Approved for Acute Migraine Treatment
Monday, January 28, 2019—The Food and Drug Administration has approved sumatriptan nasal spray 10mg (Tosymra; Promius Pharma, Princeton, NJ) for acute treatment of migraine with or without aura in adu…
Wireless Spinal Cord Stimulator Provides Relief from Chronic Pain
Friday, January 18, 2019—Clinical trial results showed that the world’s first wireless, fully programmable neuromodulation system (Freedom SCS System; Stimwave Technologies, Pompano Beach, FL) p…
Registry for Peripheral Nerve Stimulation for Pain Management Is Launched
Wednesday, January 16, 2019—The first registry related to peripheral nerve stimulation (PNS) for pain management is enrolling patients. The registry will collect long-term clinical data with the goal of …
Federal Supply Schedule Adds External Vagus Nerve Stimulator for Headache Prevention and Treatment
Tuesday, January 08, 2019—A noninvasive vagus nerve stimulation (nVNS) device (gammaCore; electroCore, Basking Ridge, NJU) has been award a 5-year Federal Supply Schedule medical equipment and supply c…
